tiprankstipranks
Trending News
More News >
Theriva Biologics (TOVX)
:TOVX
US Market

Theriva Biologics (TOVX) Cash flow

Compare
1,178 Followers

Theriva Biologics Cash Flow

TOVX's free cash flow for Q3 2025 was $-4.34M. For the 2025 fiscal year, TOVX's free cash flow was decreased by $2.26M and operating cash flow was $-4.32M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -16.94M$ -19.00M$ -19.08M$ -12.89M$ -12.17M
Investing Cash Flow
$ -1.00K$ -202.00K$ -4.40M$ -14.00K$ -9.00K
Financing Cash Flow
$ 5.50M$ 625.00K$ -1.93M$ 74.00M$ 3.36M
End Cash Position
$ 11.71M$ 23.28M$ 41.88M$ 67.33M$ 6.23M
Free Cash Flow
$ -16.94M$ -19.20M$ -19.20M$ -12.90M$ -12.18M
Currency in USD

Theriva Biologics Cash Flow